-
Signature
-
/s/ Kevin Kane as Attorney-in-Fact for Marc Fredman
-
Stock symbol
-
CCCS
-
Transactions as of
-
Mar 14, 2024
-
Transactions value $
-
-$8,223,627
-
Form type
-
4
-
Date filed
-
3/18/2024, 05:51 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CCCS |
Common Stock |
Options Exercise |
$389K |
+156K |
+67.72% |
$2.50 |
386K |
Mar 14, 2024 |
Direct |
F1 |
transaction |
CCCS |
Common Stock |
Options Exercise |
$379K |
+152K |
+39.36% |
$2.50 |
537K |
Mar 14, 2024 |
Direct |
F1 |
transaction |
CCCS |
Common Stock |
Sale |
-$3.95M |
-325K |
-60.46% |
$12.15 |
213K |
Mar 14, 2024 |
Direct |
F1, F2 |
transaction |
CCCS |
Common Stock |
Options Exercise |
$375K |
+150K |
+70.5% |
$2.50 |
362K |
Mar 15, 2024 |
Direct |
F1 |
transaction |
CCCS |
Common Stock |
Options Exercise |
$378K |
+151K |
+41.68% |
$2.50 |
513K |
Mar 15, 2024 |
Direct |
F1 |
transaction |
CCCS |
Common Stock |
Sale |
-$3.55M |
-301K |
-58.6% |
$11.81 |
213K |
Mar 15, 2024 |
Direct |
F1, F3 |
transaction |
CCCS |
Common Stock |
Options Exercise |
$297K |
+119K |
+35.58% |
$2.50 |
453K |
Mar 18, 2024 |
Direct |
F1 |
transaction |
CCCS |
Common Stock |
Options Exercise |
$303K |
+121K |
+57.04% |
$2.50 |
334K |
Mar 18, 2024 |
Direct |
F1 |
transaction |
CCCS |
Common Stock |
Sale |
-$2.84M |
-240K |
-53.03% |
$11.84 |
213K |
Mar 18, 2024 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-156K |
-30.49% |
$0.00 |
355K |
Mar 14, 2024 |
Common Stock |
156K |
$2.50 |
Direct |
F1, F5 |
transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-152K |
-29.72% |
$0.00 |
359K |
Mar 14, 2024 |
Common Stock |
152K |
$2.50 |
Direct |
F1, F6 |
transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-150K |
-42.2% |
$0.00 |
205K |
Mar 15, 2024 |
Common Stock |
150K |
$2.50 |
Direct |
F1, F5 |
transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-151K |
-42.07% |
$0.00 |
208K |
Mar 15, 2024 |
Common Stock |
151K |
$2.50 |
Direct |
F1, F6 |
transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-119K |
-57.86% |
$0.00 |
86.5K |
Mar 18, 2024 |
Common Stock |
119K |
$2.50 |
Direct |
F1, F5 |
transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-121K |
-58.29% |
$0.00 |
86.7K |
Mar 18, 2024 |
Common Stock |
121K |
$2.50 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: